Background: Necrotizing enterocolitis (NEC) is the most common gastrointestinal disorder in premature infants with a high morbidity and mortality. Paneth cell dysfunction has been suggested to be involved in the pathogenesis of NEC. Defensin alpha-6 (DEFA6) is a specific marker for Paneth cells acting as part of the innate immunity in the human intestines. The aim of this study was to investigate the expression of DEFA6 in infants with NEC.
Materials And Methods: Infants who underwent bowel resection for NEC at level III NICU in Sweden between August 2004 and September 2013 were eligible for the study. Macroscopically vital tissues were selected for histopathological evaluation. All infants in the control group underwent laparotomy and had ileostomy due to dysmotility, and samples were taken from the site of the stoma. DEFA6 expression was studied by immunohistochemistry. Digital image analysis was used for an objective and precise description of the samples.
Results: A total of 12 infants were included in the study, eight with NEC and four controls. The tissue samples were taken from the colon ( = 1), jejunum ( = 1), and ileum ( = 10). Both the NEC and control groups consisted of extremely premature and term infants (control group: 25-40 gestational weeks, NEC group: 23-39 gestational weeks). The postnatal age at the time of surgery varied in both groups (control group: 4-47 days, NEC group: 4-50 days). DEFA6 expression in the NEC group was significantly lower than that in the control group and did not correlate with gestational age.
Conclusion: The diminished DEFA6 expression in Paneth cells associated with NEC in this study supports the hypothesis that alpha-defensins are involved in the pathophysiology of NEC. Future studies are needed to elucidate the role of alpha-defensins in NEC aiming at finding preventive and therapeutic strategies against NEC.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215571 | PMC |
| http://dx.doi.org/10.1155/2018/7345426 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Regulation of Paneth cell-specific genes in COVID-19 patients and SARS-CoV-2-infected mice by quantification of mRNA from exfoliated cells in stool samples.
Sci Rep
December 2024
Division of Gastroenterology, University of Mississippi Medical Center, Jackson, MS, USA.
The Paneth cell, a secretory cell of the small intestine, expresses numerous host defense proteins, and is hypothesized to play an important role in host defense against infection. However, studying gene expression in this cell requires invasive procedures. To test the hypothesis that we could observe Paneth cell-specific gene regulation from exfoliated cells in infectious conditions, we obtained stool samples from patients with COVID-19 and uninfected controls.
View Article and Find Full Text PDFIntestinal Epithelial PTPN2 Limits Pathobiont Colonization by Immune-Directed Antimicrobial Responses.
bioRxiv
September 2024
Division of Biomedical Sciences, University of California, Riverside, Riverside, California.
Article Synopsis
- The study explores how the protein tyrosine phosphatase non-receptor type 2 (PTPN2) gene affects the colonization of a specific harmful bacteria, AIEC, in the intestines, which is linked to inflammatory bowel disease (IBD).
- Researchers used genetically modified mice to compare the effects of AIEC and a non-invasive strain on intestinal bacteria levels, immune response, and barrier function.
- Results showed that mice lacking PTPN2 had greater AIEC colonization, lower levels of protective proteins, and increased intestinal permeability, highlighting the gene's critical role in maintaining gut health.
Innate Immunity Activation in Newly Diagnosed Ileocolonic Crohn's Disease: A Cohort Study.
Dis Colon Rectum
May 2024
General Surgery Unit 3, Azienda Ospedaliera di Padova, Padua, Italy.
Background: Recent studies showed that early surgery for Crohn's disease leads to a lower recurrence rate. However, the underlying mechanism is unknown.
Objective: The study aims to analyze the innate immunity microenvironment in ileal mucosa according to the duration of Crohn's disease.
FOXO inhibition rescues α-defensin expression in human intestinal organoids.
Proc Natl Acad Sci U S A
November 2023
Department of Medical Microbiology and Immunology, School of Medicine, University of California Davis, Davis, CA 95616.
To mediate critical host-microbe interactions in the human small intestine, Paneth cells constitutively produce abundant levels of α-defensins and other antimicrobials. We report that the expression profile of these antimicrobials is dramatically askew in human small intestinal organoids (enteroids) as compared to that in paired tissue from which they are derived, with a reduction of α-defensins to nearly undetectable levels. Murine enteroids, however, recapitulate the expression profile of Paneth cell α-defensins seen in tissue.
View Article and Find Full Text PDFOat β-glucan supplementation pre- and during pregnancy alleviates fetal intestinal immunity development damaged by gestational diabetes in rats.
Food Funct
September 2023
Department of Nutrition and Food Hygiene, School of Public Health, Beijing Key Lab of Environmental Toxicology, Capital Medical University, Beijing 100069, P.R. China.
Oat β-glucan (OG) has been shown to improve intestinal microecology in gestational diabetes mellitus (GDM), but the effect on fetal intestine health is unknown. Herein, we aimed to investigate the effects of OG supplementation during gestation in GDM dams on fetal intestinal immune development. OG was supplemented one week before mating until the end of the experiment.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!